Search for: "Endo Pharmaceuticals Inc." Results 21 - 40 of 163
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Jul 2011, 9:59 pm by Patent Docs
Endo Pharmaceuticals Inc. v. [read post]
9 Jan 2009, 8:21 pm
By Jason Derry --Endo to Acquire Indevus On January 5, 2009, Endo Pharmaceuticals Holdings Inc. announced that it will buy Indevus Pharmaceuticals Inc. for an initial payment of about $370 million and an additional $267 million, based on certain milestones. [read post]
10 Jun 2010, 9:46 pm by Patent Docs
By James DeGiulio -- Endo Settles with Impax and Sandoz in Opana Patent Suits Endo Pharmaceuticals Inc. has settled patent infringement suits against Sandoz Inc. and Impax Laboratories Inc. over generic versions of painkiller Opana ER. [read post]
29 Aug 2006, 11:50 am
Patent and Trademark Office about the painkiller's effectiveness thus giving Endo Pharmaceutical Holdings Inc. the right to sell a generic version. [read post]
28 Oct 2021, 7:40 am by Simmons Hanly Conroy
While it was Judge Maltese’s court-commissioned report on APKS that grabbed media attention in recent weeks, the New York trial continues against remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
13 Jun 2010, 9:35 pm by Patent Docs
Paddock Laboratories Inc. 1:10-cv-00501; filed June 9, 2010 in the District Court of Delaware • Plaintiffs: Allergan Inc.; Allergan USA Inc.; Allergan Sales LLC; Endo Pharmaceuticals Solutions Inc.; Supernus Pharmaceuticals Inc. [read post]
20 May 2015, 1:00 am by Paul Caron
Wall Street Journal, Rules Fail To Rein In Tax-Driven Takeovers: Endo International PLC agreed to buy rival drug maker Par Pharmaceutical Holdings Inc. for $8 billion, the latest in a string of cross-border mergers steering tax revenue away from the U.S., despite Washington’s efforts. [read post]
18 Aug 2022, 11:39 am by Eileen McDermott
’s abbreviated new drug application (ANDA) does not infringe two patents owned by Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC (collectively, Par). [read post]
18 Aug 2022, 11:39 am by Eileen McDermott
’s abbreviated new drug application (ANDA) does not infringe two patents owned by Par Pharmaceutical, Inc., Par Sterile Products, LLC, and Endo Par Innovation Company, LLC (collectively, Par). [read post]
18 May 2016, 9:56 pm by Patent Docs
Endo Pharmaceuticals Inc. v. [read post]
1 Apr 2016, 5:30 am by Gene Quinn
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
4 Apr 2010, 9:55 pm by Patent Docs
Endo Pharmaceuticals Inc. 1:10-cv-00261; filed March 31, 2010 in the District Court of Delaware Infringement of U.S. [read post]
21 Feb 2014, 10:20 am by Mary Jane Wilmoth
The settlements are listed below: Endo Pharmaceuticals and Endo Health Solutions to Pay $192.7 Million to Resolve Criminal and Civil Liability Relating to Marketing of Prescription Drug Lidoderm for Unapproved Uses Pharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. [read post]
21 Sep 2011, 1:00 pm
Qualitest Pharmaceuticals, which is an entity of Endo Pharmaceuticals Holdings Inc., has recalled more than a million packages of defectively packaged birth control pills. [read post]
21 Apr 2022, 3:26 pm by PP&S Team
CVS Health Corp. and CVS Pharmacy Inc. will pay the state $484 million, while Teva Pharmaceuticals Industries Ltd. will pay $195 million, Allergan PLC over $134 million, and Endo Health Solutions $65 million. [read post]
18 May 2011, 9:20 pm by Patent Docs
The subject matter was controlled-release oxymorphone formulations, assigned to Endo Pharmaceuticals Inc. in three applications: U.S. [read post]